Abeona Therapeutics
(ABEO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,840 | 2,879 | 1,089 | -17,340 | -8,368 |
| Depreciation Amortization | 179 | 120 | 61 | 259 | 197 |
| Accounts receivable | -4 | -2 | 1 | 111 | 124 |
| Other Working Capital | -439 | -921 | -615 | 3,668 | 3,564 |
| Other Operating Activity | 4,960 | -5,905 | -2,727 | 11,054 | 3,321 |
| Operating Cash Flow | $-5,144 | $-3,829 | $-2,191 | $-2,248 | $-1,162 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -8 | N/A | -2 | -2 |
| Other Investing Activity | 0 | 0 | 0 | 1 | 1 |
| Investing Cash Flow | $-7 | $-8 | $N/A | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,040 | 5,988 | 5,862 | 179 | 158 |
| Financing Cash Flow | $6,040 | $5,988 | $5,862 | $179 | $158 |
| Beginning Cash Position | 607 | 607 | 607 | 2,677 | 2,677 |
| End Cash Position | 1,496 | 2,758 | 4,278 | 607 | 1,672 |
| Net Cash Flow | $889 | $2,151 | $3,671 | $-2,070 | $-1,005 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,144 | -3,829 | -2,191 | -2,248 | -1,162 |
| Capital Expenditure | -7 | -8 | N/A | -2 | -2 |
| Free Cash Flow | -5,151 | -3,837 | -2,191 | -2,250 | -1,164 |